Since our founding in May 1998 we have been focused on the impact of cortisol and the potential benefits of developing glucocorticoid receptor antagonists. About 80 percent of the tissues in the body have receptors for cortisol, and the effects of excess cortisol are severe and often life-threatening.


Publications show all

Corcept Therapeutics has published 32 articles.

Patents show all


Clinical Trials show all

10Phase 35Phase 23N/A3Phase 11Other

SEC Filings show all